Zobrazeno 1 - 9
of 9
pro vyhledávání: '"H. Lance Evans"'
Autor:
H. Lance Evans, Leonard E. Grosso, Jacek M. Polski, Kathleen T. Montone, Laura J. Gardner, Cherie H. Dunphy, Csaba Galambos
Publikováno v:
Archives of Pathology & Laboratory Medicine. 126:351-356
Posttransplant lymphoproliferative disorders (PTLDs) represent a morphologic, immunophenotypic, and genotypic spectrum of disease. Most recently, Knowles et al divided PTLDs into 3 distinct categories: (1) plasmacytic hyperplasia, (2) polymorphic B-c
Autor:
Cherie H. Dunphy, Gordon B. Gale, Csaba Galambos, H. Lance Evans, Jacek M. Polski, Jacqueline R. Batanian
Publikováno v:
Journal of Pediatric Hematology/Oncology. 24:50-54
We report a case of transient myeloproliferative disorder (TMD) in a neonate without features of Down syndrome (DS) with clonal karyotype evolution, after apparent spontaneous resolution of TMD, but eventually progressing to acute megakaryoblastic le
Publikováno v:
Archives of Pathology & Laboratory Medicine. 125:1227-1230
The abnormality in the translocation of chromosomes 4 and 11 (t[4;11]) has been characteristically associated with calla-negative CD15+ acute lymphoblastic leukemia (ALL) of early pre–B-cell origin. Transformation of a lymphoblastoid to a monoblast
Publikováno v:
Archives of Pathology & Laboratory Medicine. 125:1063-1069
Context.—Immunophenotyping of bone marrow (BM) specimens with acute myelogenous leukemia (AML) may be performed by flow cytometric (FC) or immunohistochemical (IH) techniques. Some markers (CD34, CD15, and CD117) are available for both techniques.
Autor:
Cherie H, Dunphy, Csaba, Galambos, Jacek M, Polski, H Lance, Evans, Laura J, Gardner, Leonard E, Grosso, Kathleen T, Montone
Publikováno v:
Archives of pathologylaboratory medicine. 126(3)
Posttransplant lymphoproliferative disorders (PTLDs) represent a morphologic, immunophenotypic, and genotypic spectrum of disease. Most recently, Knowles et al divided PTLDs into 3 distinct categories: (1) plasmacytic hyperplasia, (2) polymorphic B-c
Publikováno v:
American journal of clinical pathology. 117(1)
We studied the flow cytometric immunophenotyping (FCI) and genotypic data of 11 specimens from 10 transplant recipients and categorized them based on a scheme for posttransplant lymphoproliferative disorders (PTLDs). Specimens had been analyzed by po
Publikováno v:
Leukemialymphoma. 41(5-6)
Follicle center cell lymphoma(FCCL) has the following immunophenotype(IP): sIg+, Pan B+, CD10+/-, CD5-, CD23-/+, CD43-, CD11c-, CD25-. In addition, reactivities of a malignant lymphoma with CDw75(LN-1) and bcl-6 are considered indicators of FCCL. Bcl
Publikováno v:
Archives of Pathology & Laboratory Medicine. 127:922-922
Autor:
Dunphy CH; Division of Hematopathology, Department of Pathology, St. Louis University Health Sciences Center St. Louis, Missouri, MO 63104, USA. dunphyc@slucare1.sluh.edu, Polski JM, Lance Evans H, Gardner LJ
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2001 May; Vol. 41 (5-6), pp. 585-92.